These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28987669)

  • 1. Histogram analysis of diffusion kurtosis imaging estimates for in vivo assessment of 2016 WHO glioma grades: A cross-sectional observational study.
    Hempel JM; Schittenhelm J; Brendle C; Bender B; Bier G; Skardelly M; Tabatabai G; Castaneda Vega S; Ernemann U; Klose U
    Eur J Radiol; 2017 Oct; 95():202-211. PubMed ID: 28987669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo assessment of tumor heterogeneity in WHO 2016 glioma grades using diffusion kurtosis imaging: Diagnostic performance and improvement of feasibility in routine clinical practice.
    Hempel JM; Schittenhelm J; Bisdas S; Brendle C; Bender B; Bier G; Skardelly M; Tabatabai G; Castaneda Vega S; Ernemann U; Klose U
    J Neuroradiol; 2018 Feb; 45(1):32-40. PubMed ID: 28865921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Perfusion on Diffusion Kurtosis Imaging Estimates for In Vivo Assessment of Integrated 2016 WHO Glioma Grades : A Cross-Sectional Observational Study.
    Hempel JM; Schittenhelm J; Brendle C; Bender B; Bier G; Skardelly M; Tabatabai G; Castaneda Vega S; Ernemann U; Klose U
    Clin Neuroradiol; 2018 Dec; 28(4):481-491. PubMed ID: 28702832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histogram analysis of diffusion kurtosis imaging derived maps may distinguish between low and high grade gliomas before surgery.
    Qi XX; Shi DF; Ren SX; Zhang SY; Li L; Li QC; Guan LM
    Eur Radiol; 2018 Apr; 28(4):1748-1755. PubMed ID: 29143940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion kurtosis imaging histogram parameter metrics predicting survival in integrated molecular subtypes of diffuse glioma: An observational cohort study.
    Hempel JM; Brendle C; Bender B; Bier G; Kraus MS; Skardelly M; Richter H; Eckert F; Schittenhelm J; Ernemann U; Klose U
    Eur J Radiol; 2019 Mar; 112():144-152. PubMed ID: 30777204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.
    Kang Y; Choi SH; Kim YJ; Kim KG; Sohn CH; Kim JH; Yun TJ; Chang KH
    Radiology; 2011 Dec; 261(3):882-90. PubMed ID: 21969667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasion.
    Tsuchiya N; Doai M; Usuda K; Uramoto H; Tonami H
    PLoS One; 2017; 12(2):e0172433. PubMed ID: 28207858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo molecular profiling of human glioma using diffusion kurtosis imaging.
    Hempel JM; Bisdas S; Schittenhelm J; Brendle C; Bender B; Wassmann H; Skardelly M; Tabatabai G; Vega SC; Ernemann U; Klose U
    J Neurooncol; 2017 Jan; 131(1):93-101. PubMed ID: 27604789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status.
    Zhao J; Wang YL; Li XB; Hu MS; Li ZH; Song YK; Wang JY; Tian YS; Liu DW; Yan X; Jiang L; Yang ZY; Chu JP
    J Neurooncol; 2019 Jan; 141(1):195-203. PubMed ID: 30414095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of tissue heterogeneity using diffusion tensor and diffusion kurtosis imaging for grading gliomas.
    Raja R; Sinha N; Saini J; Mahadevan A; Rao KN; Swaminathan A
    Neuroradiology; 2016 Dec; 58(12):1217-1231. PubMed ID: 27796448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cerebral glioma using 3T diffusion kurtosis tensor imaging and the relationship between diffusion kurtosis metrics and tumor cellularity.
    Qi C; Yang S; Meng L; Chen H; Li Z; Wang S; Jiang T; Li S
    J Int Med Res; 2017 Aug; 45(4):1347-1358. PubMed ID: 28587542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion kurtosis imaging combined with molecular markers as a comprehensive approach to predict overall survival in patients with gliomas.
    Wang X; Li F; Wang D; Zeng Q
    Eur J Radiol; 2020 Jul; 128():108985. PubMed ID: 32361603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gliomas: diffusion kurtosis MR imaging in grading.
    Van Cauter S; Veraart J; Sijbers J; Peeters RR; Himmelreich U; De Keyzer F; Van Gool SW; Van Calenbergh F; De Vleeschouwer S; Van Hecke W; Sunaert S
    Radiology; 2012 May; 263(2):492-501. PubMed ID: 22403168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histogram analysis in predicting the grade and histological subtype of meningiomas based on diffusion kurtosis imaging.
    Chen X; Lin L; Wu J; Yang G; Zhong T; Du X; Chen Z; Xu G; Song Y; Xue Y; Duan Q
    Acta Radiol; 2020 Sep; 61(9):1228-1239. PubMed ID: 31986895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grading and proliferation assessment of diffuse astrocytic tumors with monoexponential, biexponential, and stretched-exponential diffusion-weighted imaging and diffusion kurtosis imaging.
    Zhang J; Chen X; Chen D; Wang Z; Li S; Zhu W
    Eur J Radiol; 2018 Dec; 109():188-195. PubMed ID: 30527302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of diffuse glioma grade and proliferation activity by different diffusion-weighted-imaging models including diffusion kurtosis imaging (DKI) and mean apparent propagator (MAP) MRI.
    Xie SH; Lang R; Li B; Zhao H; Wang P; He JL; Ma XY; Wu Q; Wang SY; Zhang HP; Gao Y; Wu JL
    Neuroradiology; 2023 Jan; 65(1):55-64. PubMed ID: 35835879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-Tumor Histogram Analysis of Multiple Diffusion Metrics for Glioma Genotyping.
    Gao A; Zhang H; Yan X; Wang S; Chen Q; Gao E; Qi J; Bai J; Zhang Y; Cheng J
    Radiology; 2022 Mar; 302(3):652-661. PubMed ID: 34874198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation.
    Jiang R; Jiang J; Zhao L; Zhang J; Zhang S; Yao Y; Yang S; Shi J; Shen N; Su C; Zhang J; Zhu W
    Oncotarget; 2015 Dec; 6(39):42380-93. PubMed ID: 26544514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion Kurtosis Imaging of Gliomas Grades II and III - A Study of Perilesional Tumor Infiltration, Tumor Grades and Subtypes at Clinical Presentation.
    Delgado AF; Fahlström M; Nilsson M; Berntsson SG; Zetterling M; Libard S; Alafuzoff I; van Westen D; Lätt J; Smits A; Larsson EM
    Radiol Oncol; 2017 Jun; 51(2):121-129. PubMed ID: 28740446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusional kurtosis imaging for differentiating between high-grade glioma and primary central nervous system lymphoma.
    Pang H; Ren Y; Dang X; Feng X; Yao Z; Wu J; Yao C; Di N; Ghinda DC; Zhang Y
    J Magn Reson Imaging; 2016 Jul; 44(1):30-40. PubMed ID: 26588793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.